Valsartan Defendants Support Economic-Loss MDL, Want Injury Cases Excluded

Mealey's (December 5, 2018, 9:17 AM EST) -- WASHINGTON, D.C. — Drug manufacturers sued because they make drugs containing valsartan on Nov. 20 supported centralization of federal lawsuits alleging economic injuries but not those alleging personal injuries in a multidistrict litigation (In Re:  Valsartan NDMA Contamination Litigation, MDL Docket No. 2875, JPMDL)....